Literature DB >> 30573424

Diagnostic criteria for amyotrophic lateral sclerosis: A multicentre study of inter-rater variation and sensitivity.

B Johnsen1, K Pugdahl2, A Fuglsang-Frederiksen2, K Kollewe3, L Paracka3, R Dengler3, J P Camdessanché4, W Nix5, R Liguori6, I Schofield7, L Maderna8, D Czell9, C Neuwirth10, M Weber10, V E Drory11, A Abraham11, M Swash12, M de Carvalho13.   

Abstract

OBJECTIVE: This study assesses inter-rater agreement and sensitivity of diagnostic criteria for amyotrophic lateral sclerosis (ALS).
METHODS: Clinical and electrophysiological data of 399 patients with suspected ALS were collected by eleven experienced physicians from ten different countries. Eight physicians classified patients independently and blinded according to the revised El Escorial Criteria (rEEC) and to the Awaji Criteria (AC). Inter-rater agreement was assessed by Kappa coefficients, sensitivity by majority diagnosis on 350 patients with follow-up data.
RESULTS: Inter-rater agreement was generally low both for rEEC and AC. Agreement was best on the categories "Not-ALS", "Definite", and "Probable", and poorest for "Possible" and "Probable Laboratory-supported". Sensitivity was equal for rEEC (64%) and AC (63%), probably due to downgrading of "Probable Laboratory-supported" patients by AC. However, AC was significantly more effective in classifying patients as "ALS" versus "Not-ALS" (p < 0.0001).
CONCLUSIONS: Inter-rater variation is high both for rEEC and for AC probably due to a high complexity of the rEEC inherent in the AC. The gain of AC on diagnostic sensitivity is reduced by the omission of the "Probable Laboratory-supported" category. SIGNIFICANCE: The results highlight a need for initiatives to develop simpler and more reproducible diagnostic criteria for ALS in clinical practice and research.
Copyright © 2018 International Federation of Clinical Neurophysiology. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Awaji criteria; Diagnostic criteria; Electrodiagnosis; Electromyography; Inter-rater variation; Revised El Escorial criteria

Mesh:

Year:  2018        PMID: 30573424     DOI: 10.1016/j.clinph.2018.11.021

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  8 in total

1.  Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis.

Authors:  Eleonora Colombo; Alberto Doretti; Francesco Scheveger; Alessio Maranzano; Giulia Pata; Delia Gagliardi; Megi Meneri; Stefano Messina; Federico Verde; Claudia Morelli; Stefania Corti; Luca Maderna; Vincenzo Silani; Nicola Ticozzi
Journal:  J Neurol       Date:  2022-10-02       Impact factor: 6.682

2.  Intentions of Canadian health professionals towards recommending exercise for people living with ALS.

Authors:  Kelvin E Jones; Tanya R Berry; Aaliya S Merali; Vanina Dal Bello-Haas
Journal:  BMC Neurol       Date:  2019-08-22       Impact factor: 2.474

Review 3.  Considerations on the concept, definition, and diagnosis of amyotrophic lateral sclerosis.

Authors:  Ren-Shi Xu; Min Yuan
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

Review 4.  Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective.

Authors:  Charis Wong; Maria Stavrou; Elizabeth Elliott; Jenna M Gregory; Nigel Leigh; Ashwin A Pinto; Timothy L Williams; Jeremy Chataway; Robert Swingler; Mahesh K B Parmar; Nigel Stallard; Christopher J Weir; Richard A Parker; Amina Chaouch; Hisham Hamdalla; John Ealing; George Gorrie; Ian Morrison; Callum Duncan; Peter Connelly; Francisco Javier Carod-Artal; Richard Davenport; Pablo Garcia Reitboeck; Aleksandar Radunovic; Venkataramanan Srinivasan; Jenny Preston; Arpan R Mehta; Danielle Leighton; Stella Glasmacher; Emily Beswick; Jill Williamson; Amy Stenson; Christine Weaver; Judith Newton; Dawn Lyle; Rachel Dakin; Malcolm Macleod; Suvankar Pal; Siddharthan Chandran
Journal:  Brain Commun       Date:  2021-10-23

5.  Motor unit integrity in multifocal motor neuropathy: A systematic evaluation with CMAP scans.

Authors:  Diederik J L Stikvoort García; Maria O Kovalchuk; H Stephan Goedee; Leonard J van Schelven; Leonard H van den Berg; Hessel Franssen; Boudewijn T H M Sleutjes
Journal:  Muscle Nerve       Date:  2021-12-16       Impact factor: 3.852

Review 6.  Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?

Authors:  Bradley Roberts; Frances Theunissen; Francis L Mastaglia; P Anthony Akkari; Loren L Flynn
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

7.  Amyotrophic lateral sclerosis in seven provinces of Chinese mainland: A cross-sectional survey from 2015 to 2016.

Authors:  Jie Zhang; Xiaoqing Liu; Huiting Liang; Shengyuan Xu; Xiaohua Wang; Renshi Xu
Journal:  Front Aging Neurosci       Date:  2022-09-15       Impact factor: 5.702

8.  The Gold Coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a Chinese population.

Authors:  Dongchao Shen; Xunzhe Yang; Yanying Wang; Di He; Xiaohan Sun; Zhengyi Cai; Jinyue Li; Mingsheng Liu; Liying Cui
Journal:  Transl Neurodegener       Date:  2021-08-09       Impact factor: 8.014

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.